Updated PRES recommendations for coronavirus outbreak
PReS would like to share important recommendations for patients, families and doctors in the context of the COVID-19 pandemic. September 2020 update.
More
EMERGE NEWSLETTER - JULY 2020
In this newsletter: YIM 2020 is going virtual!!, ERN-RITA webinar, PReS Scleroderma working party invitation
More
COVID-19 pediatric rheumatology survey
EMERGE group and Clinical Affairs Committee of the PReS council invite you to take a short survey.
More
Message from PReS Executive Committee
Dear Colleagues, dear Friends,
In these uncertain and troubled times, we would like to send our sincere good wishes to you, your families, colleagues and patients.
The PReS Council and Scientific Organizing Committee of the PReS 2020 Congress have been carefully analysing the situation regarding the congress in September.
PReS endorses the COVID-19 Global Rheumatology Alliance
COVID-19 Global Rheumatology Alliance is a large group of academics, clinicians and patients working to establish a global freely accessible registry where doctors can add details of their patients who either (1) Have a rheumatic disease, or (2) Are on a drug used in rheumatology who become infected with COVID-19.
More